Search Results - Dahl, Ronald, Prof

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use

    Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use by Dahl, Ronald, Prof, Doherty, Dennis E., Prof, Corren, Jonathan, MD, Karpel, Jill, Dr, Kerstjens, Huib A.M, Engel, Michael, Dr, Moroni-Zentgraf, Petra, Dr, Schmidt, Hendrik, Dr, Hashimoto, Shu, Dr

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Tiotropium Respimat® Add-On Therapy Reduces Airflow Obstruction In Patients With Symptomatic Moderate Asthma, Independent Of TH 2 Inflammatory Status

    Tiotropium Respimat® Add-On Therapy Reduces Airflow Obstruction In Patients With Symptomatic Moderate Asthma, Independent Of TH 2 Inflammatory Status by Casale, Thomas B., Dr, Bateman, Eric Donn, Dr, Dahl, Ronald, Prof, Pizzichini, Emilio, Dr, Vandewalker, Mark L., Dr, Virchow, Johann Christian, Dr, Engel, Michael, Dr, Moroni-Zentgraf, Petra, Dr, Schmidt, Hendrik, Dr, Kerstjens, Huib A.M

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

    Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials by Chaturvedi, Nish, Prof, Porta, Massimo, Prof, Klein, Ronald, Prof, Orchard, Trevor, Prof, Fuller, John, Prof, Parving, Hans Henrik, Prof, Bilous, Rudy, Prof, Sjølie, Anne Katrin, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

    Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial by Sjølie, Anne Katrin, Prof, Klein, Ronald, Prof, Porta, Massimo, Prof, Orchard, Trevor, Prof, Fuller, John, Prof, Parving, Hans Henrik, Prof, Bilous, Rudy, Prof, Chaturvedi, Nish, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: